openPR Logo
Press release

Thyroid Gland Disorder Treatment Market Trends, Growth, Analysis and Forecast - 2025

07-01-2020 03:35 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Disorder Treatment Market

Disorder Treatment Market

The global thyroid gland disorder market is growing at a significant CAGR during the forecast period. One of the major factors that is augmenting the growth of the market is the rising incidence of thyroid gland disorder. thyroid hormones are necessary for growth, neural development, and reproduction & regulation of energy metabolism. Thyroid gland disorder has two most common types comprising hypothyroidism and hyperthyroidism. Further, rapid development of new and effective therapies to cure thyroid gland disorder is assisting tremendously in the growth of the market. According to American thyroid association, there are currently 20 million suffering from thyroid gland disease, and it has also estimated that almost 12% of the US population will develop one kind of thyroid disease during their lifetime. Hence there is a lucrative opportunity for key market players in the region.

Get Sample Copy of Thyroid Gland Disorder Treatment Market at: https://www.omrglobal.com/request-sample/thyroid-gland-disorder-treatment-market

The key market players dominating the global thyroid gland disorder market include Abbvie Inc., Amgen Inc., GlaxoSmithKline PLC, Merck KGaA, Mylan NV, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Elexis Inc. and IBSA Pharma (IBSA Group).

Further, other major factors such as a rise in collaborations between private and government organizations across the globe to increase the awareness program are expected to substantially assist the market growth in the coming years. For instance, in 2017, Merck a US-based healthcare company launched a campaign named “It’s not you. It’s your thyroid” to increase the awareness of the disease among common citizens. Moreover, the rise in the consumption of tobacco and alcohol is also a major factor in assisting in the growth of the market. As smoking is rising among the general people across the globe, there are more and more people who suffer from thyroid disease.

The rising number of patients with iodine deficiencies in developed and developing economies is assisting in the prevalence of thyroid disease. Food and nutritional supplements rich in iodine are some of the most effective ways of curing iodine deficiency. According to the world health organization, 150 mcg per day is the daily recommended intake for iodine in healthy adults, whereas lactating and pregnant women require a little more than that. Iodine deficiency is the most prevalent in European nations followed by developing economies in the region such as Asia-Pacific and Africa. According to the National Institute of health iodine deficient is most common in mountainous regions of the US and Mexico.

For More Information, gets A full report of Thyroid Gland Disorder Treatment Market is available at: https://www.omrglobal.com/industry-reports/thyroid-gland-disorder-treatment-market

Furthermore, the easy availability of drugs and medicines primarily owing to the rising popularity of ecommerce is aiding in the market growth substantially. However, stringent government regulations coupled with side-effects of the thyroid gland disorder treatment is anticipated to restrain the market growth. Geographical expansion, merger & acquisition, finding a new market or innovate in their core competency in order to expand individual market share is a key strategy adopted by major market players.

Global Thyroid Gland Disorder Treatment Market- Segment

By Type

• Hyperthyroidism
• Hypothyroidism
• Thyroid Cancers

By Route of Administration

• Oral
• Parenteral
• Others

Global Thyroid Gland Disorder Treatment Market- Regional

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/thyroid-gland-disorder-treatment-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Thyroid Gland Disorder Treatment Market Trends, Growth, Analysis and Forecast - 2025 here

News-ID: 2082977 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Disorder

Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder …
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate? The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to
Autism Spectrum Disorder Therapeutics Market: "Autism Spectrum Disorder Therapie …
Autism Spectrum Disorder Therapeutics Market Scope: Key Insights : Autism Spectrum Disorder Therapeutics Market size was valued at USD 1.92 billion in 2022 and is poised to grow from USD 2.07 billion in 2023 to USD 3.77 billion by 2031, growing at a CAGR of 7.80% during the forecast period (2024-2031). Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/autism-spectrum-disorder-therapeutics-market In-Depth Exploration of the global Autism Spectrum Disorder Therapeutics
Bipolar Disorder Therapeutics Market Report 2024 - Bipolar Disorder Market Oppor …
"The Business Research Company recently released a comprehensive report on the Global Bipolar Disorder Therapeutics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Bipolar Disorder Therapeutics Market: Balancing the Mind - Unveiling Breakthroug …
Allied Market Research recently said Bipolar disorder, a mental health condition characterized by extreme shifts in mood and energy levels, affects millions of people worldwide. The quest for effective therapeutics to manage this complex disorder has seen remarkable progress in recent years. This article explores the innovative developments in bipolar disorder therapeutics, shedding light on the path to achieving a harmonious balance for those living with this condition. ♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞
Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior. Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms